scholarly journals Coexistence of amyloid-β and Tau hyperphosphorylation rescues cognitive and electrophysiological deficiencies in a mouse model of Alzheimer’s disease

2020 ◽  
Author(s):  
Eva Dávila-Bouziguet ◽  
Arnau Casòliba-Melich ◽  
Georgina Targa-Fabra ◽  
Lorena Galera-López ◽  
Andrés Ozaita ◽  
...  

AbstractAlzheimer’s disease hallmarks include amyloid-β peptide (Aβ) and hyperphosphorylated Tau (P-Tau), abnormalities in hippocampal oscillatory rhythms, imbalance of neuronal activity, and cognitive deficits. J20 and VLW mice, accumulating Aβ and P-Tau, respectively, show imbalanced neuronal activity and cognitive impairments. Here we analyzed mice simultaneously accumulating Aβ and P-Tau (J20/VLW). No changes in Aβ load or in P-Tau in pyramidal cells were observed in J20/VLW animals compared to respective single transgenic models. Conversely, the density of hippocampal interneurons accumulating pThr205 and pSer262 Tau was higher in J20/VLW than in VLW mice. The GABAergic septohippocampal (SH) connection specifically innervates hippocampal interneurons, modulating hippocampal electrophysiology. Contrarily to previous results showing an important reduction of GABAergic SH innervation in J20 and VLW mice, here we demonstrate that the GABAergic SH connection is preserved in J20/VLW animals. Furthermore, our findings indicate that hippocampal theta rhythms, markedly diminished in J20 and VLW mice, are partially rescued in J20/VLW animals. Moreover, the simultaneous presence of Aβ and P-Tau rescues Aβ-associated recognition memory deficits in J20/VLW mice. Altogether, these data suggest that a differential Tau phosphorylation pattern in hippocampal interneurons protects against loss of GABAergic SH innervation, preventing alterations in local field potentials and avoiding cognitive deficits.

Brain ◽  
2021 ◽  
Author(s):  
Eva Dávila-Bouziguet ◽  
Arnau Casòliba-Melich ◽  
Georgina Targa-Fabra ◽  
Lorena Galera-López ◽  
Andrés Ozaita ◽  
...  

Abstract Alzheimer’s disease comprises amyloid-β and hyperphosphorylated Tau accumulation, imbalanced neuronal activity, aberrant oscillatory rhythms, and cognitive deficits. Non-Demented with Alzheimer’s disease Neuropathology (NDAN) defines a novel clinical entity with amyloid-β and Tau pathologies but preserved cognition. The mechanisms underlying such neuroprotection remain undetermined and animal models of NDAN are currently unavailable. We demonstrate that J20/VLW mice (accumulating amyloid-β and hyperphosphorylated Tau) exhibit preserved hippocampal rhythmic activity and cognition, as opposed to J20 and VLW animals, which show significant alterations. Furthermore, we show that the overexpression of mutant human Tau in coexistence with amyloid-β accumulation renders a particular hyperphosphorylated Tau signature in hippocampal interneurons. The GABAergic septohippocampal pathway, responsible for hippocampal rhythmic activity, is preserved in J20/VLW mice, in contrast to single mutants. Our data highlight J20/VLW mice as a suitable animal model in which to explore the mechanisms driving cognitive preservation in NDAN. Moreover, they suggest that a differential Tau phosphorylation pattern in hippocampal interneurons prevents the loss of GABAergic septohippocampal innervation and alterations in local field potentials, thereby avoiding cognitive deficits.


PLoS ONE ◽  
2019 ◽  
Vol 14 (4) ◽  
pp. e0215004 ◽  
Author(s):  
Deborah A. Roby ◽  
Fernanda Ruiz ◽  
Bailey A. Kermath ◽  
Jaymie R. Voorhees ◽  
Michael Niehoff ◽  
...  

2020 ◽  
Author(s):  
Sourav Samanta ◽  
Kolla Rajasekhar ◽  
Madhu Ramesh ◽  
N. Arul Murugan ◽  
Shadab Alam ◽  
...  

ABSTRACTAlzheimer’s disease (AD) is a major neurodegenerative disorder and the leading cause of dementia worldwide. Predominantly, misfolding and aggregation of amyloid-β (Aβ) peptides associated with multifaceted toxicity is the neuropathological hallmark of AD pathogenesis and thus, primary therapeutic target to ameliorate neuronal toxicity and cognitive deficits. Herein, we report the design, synthesis and evaluation of small molecule inhibitors with naphthalene monoimide scaffold to ameliorate in vitro and in vivo amyloid induced neurotoxicity. The detailed studies established TGR63 as the lead candidate to rescue neuronal cells from amyloid toxicity. The in silico studies showed disruption of salt bridges and intermolecular hydrogen bonding interactions within Aβ42 fibrils by the interaction of TGR63, causing destabilization of Aβ42 assembly. Remarkably, TGR63 treatment showed a significant reduction in cortical and hippocampal amyloid burden in the progressive stages of APP/PS1 AD mice brain. Various behavioral tests demonstrated rescued cognitive deficits. The excellent biocompatibility, BBB permeability and therapeutic efficacy to reduce amyloid burden make TGR63 a promising candidate for the treatment of AD.


2014 ◽  
Vol 39 (2) ◽  
pp. 357-370 ◽  
Author(s):  
Carlos A. Ribeiro ◽  
Sandra Marisa Oliveira ◽  
Luis F. Guido ◽  
Ana Magalhães ◽  
Gregorio Valencia ◽  
...  

2005 ◽  
Vol 332 (2) ◽  
pp. 585-592 ◽  
Author(s):  
Venkatarajan S. Mathura ◽  
Daniel Paris ◽  
Ghania Ait-Ghezala ◽  
Amita Quadros ◽  
Nikunj S. Patel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document